Serena Williams Defends Use of GLP-1 Drug for Weight Loss

Serena Williams, a 23-time Grand Slam champion, has publicly defended her use of GLP-1 medication, specifically Zepbound, which she credits for her 34-pound weight loss prior to her return to professional tennis after a four-year hiatus. Williams stated that her association with the treatment is "no big deal," as it offers more than just weight loss benefits.

She explained that GLP-1 medications have improved her overall health, reducing her risk of heart disease and enhancing diabetic indicators and inflammation. Williams was unaware of her heart disease risk until she underwent testing.

Initially, she faced restrictions on what she could disclose about the medication due to ongoing research. Her connection to Ro, the telehealth company distributing GLP-1 medications, stems from her husband, Alexis Ohanian, being an early investor.

Williams expressed admiration for Ro's mission and referred to GLP-1 treatments as "a miracle for many people.".